PERTH, Australia – Australia's medical research institutes generated more than 18,000 research contracts and collaborations in 2016, which resulted in more than AU$1.9 billion (US$1.37 billion) in income, according to a new survey conducted by Australia's Department of Industry, Innovation and Science.
PERTH, Australia – Australia's medical research institutes generated more than 18,000 research contracts and collaborations in 2016, which resulted in more than AU$1.9 billion (US$1.37 billion) in income, according to a new survey conducted by Australia's Department of Industry, Innovation and Science.
PERTH, Australia – Like many Aussie companies, Invion Ltd. started out with some assets that it had a difficult time progressing forward, and it ended up remaking itself into a completely different company with new assets. Now, Melbourne-headquartered Invion plans to enter the clinic early this year with a photosensitizer therapy to treat melanoma.
PERTH, Australia – Stress is often a factor that contributes to many conditions ranging from psoriasis to irritable bowel syndrome, but it also has an effect on the brain, and recent evidence has shown that stress may be involved in accelerating the onset of Alzheimer's disease as well as worsening the course of the disease.
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is launching a pilot good clinical practices (GCP) program in the hopes of launching a routine GCP inspections program.
PERTH, Australia – Australia's Neuclone Pharmaceuticals Ltd. is developing a broad pipeline of biosimilars, and it plans on being a big disrupter to the global pharma market.
PERTH, Australia – Stress is often a factor that contributes to many conditions ranging from psoriasis to irritable bowel syndrome, but it also has an effect on the brain, and recent evidence has shown that stress may be involved in accelerating the onset of Alzheimer's disease as well as worsening the course of the disease.
PERTH, Australia – Australia's Neuclone Pharmaceuticals Ltd. is developing a broad pipeline of biosimilars, and it plans on being a big disrupter to the global pharma market.
